Limited coverage drugs – ondansetron

Last updated on September 26, 2024

Generic name / strength / form

ondansetron - all strengths and forms

Criteria

Approval period

Prevention and treatment of nausea and vomiting associated with chemotherapy.

First approval: six months

Renewals: six months

Practitioner exemptions

  • Oncologist (medical)
  • Oncologist (radiation)

Special notes

  • None

Special Authority requests